Report cover image

Interventional Neuroradiology Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385577

Description

Interventional Neuroradiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Device Type: Microcatheters; Neurovascular Embolization And Coiling Assist Devices; Embolic Coils; Flow Diversion Devices; Liquid Embolic Agents; Accessories; Micro Guidewires

2) By Disease: Cerebral Aneurysms; Intra-Cranial Tumors; Acute Strokes; Other Diseases

3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers

Subsegments:

1) By Microcatheters: Single-Lumen Microcatheters; Dual-Lumen Microcatheters; High-Flow Microcatheters

2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices; Embolization Assist Devices

3) By Embolic Coils: Soft Coils; Stiff Coils; Detachable Coils

4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices; Non-Stent-Based Flow Diversion Devices

5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents; Gel-Based Liquid Embolic Agents; Onyx Liquid Embolic Agents

6) By Accessories: Guide Catheters; Sheath Introducers; Vascular Access Devices

7) By Micro Guidewires: Hydrophilic Micro Guidewires; Pushable Micro Guidewires; Coated Micro Guidewires

Companies Mentioned: Bayer HealthCare; Abbott Laboratories; Medtronic PLC; Siemens Healthineers AG; Fujifilm Corporation; Philips Healthcare; Stryker Corporation; GE Healthcare Life Sciences; Boston Scientific Corporation; Terumo Corporation; Canon Medical Systems Corporation; W. L. Gore & Associates Inc.; Teleflex Incorporated; Cook Medical LLC; Biotronik SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Guerbet Group; Mediterra LLC; Acandis GmbH; Medico's Hirata Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Glaucoma Market Characteristics
3. Glaucoma Market Trends And Strategies
4. Glaucoma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Glaucoma Growth Analysis And Strategic Analysis Framework
5.1. Global Glaucoma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Glaucoma Market Growth Rate Analysis
5.4. Global Glaucoma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Glaucoma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Glaucoma Total Addressable Market (TAM)
6. Glaucoma Market Segmentation
6.1. Global Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Angle Glaucoma
Angle Closure Glaucoma
Other Disease Types
6.2. Global Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tonometry
Ophthalmoscopy
Perimetry
Gonioscopy
6.3. Global Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta Blockers
Prostaglandins
Alpha Adrenergic Agonist
Carbonic Anhydrase Inhibitors
Combination Drugs
Other Drug Classes
6.4. Global Glaucoma Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injections
Intravitreal
Other Administrations
6.5. Global Glaucoma Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
6.6. Global Glaucoma Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Open Angle Glaucoma (POAG)
Secondary Open Angle Glaucoma
6.7. Global Glaucoma Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Angle Closure Glaucoma
Secondary Angle Closure Glaucoma
6.8. Global Glaucoma Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Normal-Tension Glaucoma
Pigmentary Glaucoma
Pseudoexfoliative Glaucoma
Congenital Glaucoma
7. Glaucoma Market Regional And Country Analysis
7.1. Global Glaucoma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Glaucoma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Glaucoma Market
8.1. Asia-Pacific Glaucoma Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Glaucoma Market
9.1. China Glaucoma Market Overview
9.2. China Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Glaucoma Market
10.1. India Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Glaucoma Market
11.1. Japan Glaucoma Market Overview
11.2. Japan Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Glaucoma Market
12.1. Australia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Glaucoma Market
13.1. Indonesia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Glaucoma Market
14.1. South Korea Glaucoma Market Overview
14.2. South Korea Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Glaucoma Market
15.1. Western Europe Glaucoma Market Overview
15.2. Western Europe Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Glaucoma Market
16.1. UK Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Glaucoma Market
17.1. Germany Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Glaucoma Market
18.1. France Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Glaucoma Market
19.1. Italy Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Glaucoma Market
20.1. Spain Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Glaucoma Market
21.1. Eastern Europe Glaucoma Market Overview
21.2. Eastern Europe Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Glaucoma Market
22.1. Russia Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Glaucoma Market
23.1. North America Glaucoma Market Overview
23.2. North America Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Glaucoma Market
24.1. USA Glaucoma Market Overview
24.2. USA Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Glaucoma Market
25.1. Canada Glaucoma Market Overview
25.2. Canada Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Glaucoma Market
26.1. South America Glaucoma Market Overview
26.2. South America Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Glaucoma Market
27.1. Brazil Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Glaucoma Market
28.1. Middle East Glaucoma Market Overview
28.2. Middle East Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Glaucoma Market
29.1. Africa Glaucoma Market Overview
29.2. Africa Glaucoma Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Glaucoma Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Glaucoma Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Glaucoma Market Competitive Landscape And Company Profiles
30.1. Glaucoma Market Competitive Landscape
30.2. Glaucoma Market Company Profiles
30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Teva Pharmaceuticals Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Glaucoma Market Other Major And Innovative Companies
31.1. Otsuka Pharmaceutical Co. Ltd.
31.2. Sun Pharmaceutical Industries Ltd.
31.3. Cipla Limited
31.4. Bausch & Lomb Corp.
31.5. Carl Zeiss Meditec
31.6. Santen Pharmaceuticals Co. Ltd.
31.7. Topcon Corporation
31.8. Thea Laboratoires
31.9. Corza Ophthalmology
31.10. Lumenis Ltd.
31.11. Alcon Inc.
31.12. Viva BioInnovator
31.13. Glaukos Corporation
31.14. Iridex Corporation
31.15. Nova Eye Medical Ltd.
32. Global Glaucoma Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Glaucoma Market
34. Recent Developments In The Glaucoma Market
35. Glaucoma Market High Potential Countries, Segments and Strategies
35.1 Glaucoma Market In 2029 - Countries Offering Most New Opportunities
35.2 Glaucoma Market In 2029 - Segments Offering Most New Opportunities
35.3 Glaucoma Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.